Effect of Gemcitabine on Mouse Jejunum Radiosensitization
Author Information
Author(s): V Gregoire, M Beauduin, J-F Rosier, B De Coster, M Bruniaux, M Octave-Prignot, P Scalliet
Primary Institution: UCL St-Luc University Hospital
Hypothesis
The study aims to determine the effect of dFdC on mouse jejunum radiosensitization and investigate the kinetics of DNA synthesis inhibition and cell cycle redistribution.
Conclusion
Gemcitabine alters the radioresponse of the mouse jejunum in a schedule-dependent manner, with radiosensitization observed shortly after administration.
Supporting Evidence
- Gemcitabine inhibited DNA synthesis within 3 hours after administration.
- Radiosensitization was observed for a 3-hour time interval with a dose modification factor of 1.3.
- A slight radioprotection was observed for a 48-hour time interval with a dose modification factor of 0.9.
- DNA synthesis inhibition and cell cycle redistribution are suggested as surrogates for radiosensitization.
Takeaway
This study looks at how a drug called gemcitabine affects the ability of mouse intestines to handle radiation, showing that it can make the intestines more sensitive to radiation if given at the right time.
Methodology
Mice were irradiated with gamma rays and treated with gemcitabine to assess jejunum tolerance and DNA synthesis inhibition.
Limitations
More data points are required before a definite conclusion can be drawn.
Participant Demographics
Ten- to twelve-week-old male C3H mice were used.
Statistical Information
P-Value
p<0.05
Confidence Interval
13.09-14.84 Gy
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website